A PHASE-II STUDY OF ORAL ETOPOSIDE IN ELDERLY PATIENTS WITH SMALL CELL LUNG-CANCER

被引：77
|
作者：
SMIT, EF
CARNEY, DN
HARFORD, P
SLEIJFER, DT
POSTMUS, PE
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT PULM DIS,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,DEPT INTERNAL MED,DIV MED ONCOL,9713 EZ GRONINGEN,NETHERLANDS
[3] ST LUKES HOSP,DUBLIN,IRELAND
来源：
THORAX | 1989年 / 44卷 / 08期
关键词：
D O I：
10.1136/thx.44.8.631
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：631 / 633
页数：3
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF DAILY ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
    SAXMAN, S
    LOEHRER, PJ
    LOGIE, K
    STEPHENS, D
    WORKMAN, F
    SCULLIN, D
    EINHORN, LH
    ANSARI, R
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) : 253 - 256
  • [2] ORAL ETOPOSIDE PRECEDING CISPLATIN IN ADVANCED NON SMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY
    FOCAN, C
    VANDERMOTEN, G
    BOOSSY, J
    SCHALLIER, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09): : 1515 - 1520
  • [3] MULTICENTER PHASE-II TRIAL OF ETOPOSIDE IN REFRACTORY SMALL CELL LUNG-CANCER
    ISSELL, BF
    EINHORN, LH
    COMIS, RL
    LAWSON, RD
    BAKER, LH
    HARVEY, HA
    LANZOTTI, VA
    WAMPLER, GL
    DANIELS, JR
    ANDERSON, PN
    HONG, WK
    RENTSCHLER, RE
    PIKLER, GM
    MAROUN, JA
    WERNZ, JC
    ROSENBAUM, PF
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 127 - 128
  • [4] PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL
    WAITS, TM
    JOHNSON, DH
    HAINSWORTH, JD
    HANDE, KR
    THOMAS, M
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 292 - 296
  • [5] PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL
    JOHNSON, DH
    GRECO, FA
    STRUPP, J
    HANDE, KR
    HAINSWORTH, JD
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) : 1613 - 1617
  • [6] PHASE-II STUDY OF CARBOPLATIN IN SMALL CELL LUNG-CANCER
    TAMURA, T
    SAIJO, N
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    SAKURAI, M
    FUJIWARA, Y
    NAKANO, H
    NAKAGAWA, K
    MINATO, K
    HONG, WS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1988, 18 (01) : 27 - 32
  • [7] PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
    HSIEH, RK
    CHANG, AYC
    BOROS, L
    ASBURY, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06): : 509 - 513
  • [8] PHASE-II RANDOMIZED STUDY OF CISPLATIN PLUS ETOPOSIDE PHOSPHATE OR ETOPOSIDE IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    HAINSWORTH, JD
    LEVITAN, N
    WAMPLER, GL
    BELANI, CP
    SEYEDSADR, MS
    RANDOLPH, J
    SCHACTER, LP
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (06) : 1436 - 1442
  • [9] A PHASE-II STUDY OF VINDESINE PLUS ETOPOSIDE IN METASTATIC NON-SMALL-CELL LUNG-CANCER
    HUPPERETS, PSGJ
    TENVELDE, GPM
    BRON, H
    SCHOUTEN, L
    BLIJHAM, GH
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (05) : 674 - 675
  • [10] HIGH-DOSE ETOPOSIDE FOR BRAIN METASTASES OF SMALL CELL LUNG-CANCER - A PHASE-II STUDY
    POSTMUS, PE
    HAAXMAREICHE, H
    SLEIJFER, DT
    KIRKPATRICK, A
    MCVIE, JG
    KLEISBAUER, JP
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 254 - 256
12345